Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

Recent & Breaking News (TSX:BCT)

BriaCell Continues Clinical Operations Amidst COVID-19 Pandemic

GlobeNewswire March 26, 2020

BriaCell to Present Clinical and Immune Activity at AACR Annual Meeting

GlobeNewswire February 26, 2020

BriaCell Announces Proposed Public Offering in the United States and Listing on NASDAQ

GlobeNewswire February 21, 2020

BriaCell Announces Grant to Investigator Dr. Saveri Bhattacharya at Sidney Kimmel Cancer Center - Jefferson Health for Phase I/IIa Combination Study of Bria-IMT(TM)

GlobeNewswire February 11, 2020

BriaCell's Clinical Data Accepted to be Presented at the Annual Symposium of Society of Surgical Oncology 2020 in Boston

GlobeNewswire January 28, 2020

BriaCell Invited to Present at Mount Sinai's Frontiers in Academic Pathology Symposium at The New York Academy of Medicine

GlobeNewswire January 22, 2020

BriaCell Provides Update on Remarkable Responder

GlobeNewswire January 13, 2020

BriaCell Outlines New High Responding Patient Group 'Biomarker' Based on Cancer Grade

GlobeNewswire January 9, 2020

BriaCell Completes Share Consolidation

GlobeNewswire January 2, 2020

BriaCell Therapeutics Corp. Announces Share Consolidation

GlobeNewswire December 24, 2019

BriaCell to Present at Biotech Showcase(TM) 2020 in San Francisco

GlobeNewswire December 17, 2019

BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®

GlobeNewswire December 13, 2019

BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th

GlobeNewswire November 12, 2019

BriaCell Announces Voting Results of the Special Meeting of Shareholders

GlobeNewswire October 24, 2019

BriaCell Announces Closing of Non-Brokered Private Placement of $568,444

GlobeNewswire October 15, 2019

BriaCell Therapeutics Corp. to File Amendment to Management Information Circular

GlobeNewswire October 8, 2019

BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT(TM) in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer

GlobeNewswire October 7, 2019

BriaCell Therapeutics Corp. to Clarify Record Date

GlobeNewswire October 1, 2019

Note from Chairman of BriaCell Therapeutics - October is Breast Cancer Awareness Month

GlobeNewswire October 1, 2019

BriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker, to Scientific Advisory Board; BriaCell CEO to Lead Special 'Targeted Immunotherapy' Issue in Prestigious Journals

GlobeNewswire September 25, 2019